Shoko Furukawa

10PUBLICATIONS
9CO-AUTHORS
Models of care and place of birthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyMicrofluidics and nanofluidicsEndodontics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 21, 2026
Maternal-fetal transfer of emicizumab in a pregnant mouse model.

|Dec 07, 2023
Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity.

Kuniyoshi Mizumachi, Yuto Nakajima, Naruto Shimonishi

|Nov 30, 2023
Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot® ) evaluated by global coagulation assay in patients with acquired haemophilia A.

Masahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara

|Apr 11, 2023
Intra-articular haemorrhage caused by reduced recovery of PEGylated recombinant factor VIII due to an anti-PEG antibody developed after mRNA-1273 SARS-CoV-2 vaccination in haemophilia A.

Yuto Nakajima, Kenichi Ogiwara, Naruto Shimonishi

|Feb 13, 2023
Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations.

Naruto Shimonishi, Kenichi Ogiwara, Junko Yoshida

|Sep 27, 2022
Peri-operative hemostatic management of tooth extraction in patients with hemophilia A, with and without inhibitors, receiving emicizumab prophylaxis.

Takahiro Yagyuu, Shoko Furukawa, Miki Zaizen

Pageof 2

Frequent Collaborators

7 joint publications

Keiji Nogami

5 joint publications

Naruto Shimonishi

5 joint publications

Masahiro Takeyama

4 joint publications

Yuto Nakajima